From a molecular clinical viewpoint, Relafen 750 ( Naproxen Sodium ) presents a unique case. Its mechanism read more of action primarily involves inhibiting cyclooxygenase enzymes , specifically COX-1 and COX-2, thereby reducing prostaglandin production . This contributes to decreased pain and temperature . The drug's relatively long half-life and